mTOR Regulator DEPTOR Controls Brain Cholesterol and Neurological Function
Disrupting DEPTOR in zebrafish causes cholesterol buildup, axonal defects, and motor problems — implicating mTOR-lipid crosstalk in brain disease.
Summary
The mTOR signaling pathway is central to aging and neurological health, but the role of DEPTOR — its natural brake — in the brain has been largely unknown. Researchers used CRISPR gene editing to knock out deptor in zebrafish and discovered that larvae develop motor deficits and structural abnormalities in axonal tracts. These problems were linked to dysregulated cholesterol metabolism: key cholesterol-regulatory genes were disrupted, and cholesterol progressively accumulated in the brain. Artificially raising cholesterol in normal fish reproduced these defects, while clearing excess cholesterol from mutant fish rescued them. The findings reveal a previously unknown connection between DEPTOR, cholesterol homeostasis, and neurodevelopment, suggesting that cholesterol management may be a therapeutic entry point for neurological conditions tied to mTOR dysfunction.
Detailed Summary
The mTOR signaling pathway governs cellular growth, metabolism, and survival across nearly all organisms, and its dysregulation is a hallmark of aging, cancer, and neurodegeneration. DEPTOR is an endogenous protein that brakes both mTOR complex 1 and mTOR complex 2. Despite extensive study in cancer and peripheral metabolism, DEPTOR's function in the nervous system had remained poorly characterized — a gap this study set out to close.
Using CRISPR/Cas9 technology, researchers at Fudan University deleted the deptor gene in zebrafish larvae. The knockout animals developed clear motor deficits and displayed structural axonal abnormalities — specifically, misaligned and broadened axonal tracts — pointing to disrupted neuronal wiring during development.
Mechanistic analysis revealed that deptor loss caused transcriptional dysregulation of key cholesterol-regulatory genes, followed by progressive, abnormal cholesterol accumulation in the brain between 5 and 10 days post-fertilization. To confirm causality, the team pharmacologically elevated cholesterol in wild-type fish and successfully reproduced the axonal and behavioral defects seen in mutants. Crucially, clearing excess cholesterol in the mutant fish rescued the phenotype, establishing cholesterol dysregulation as the primary driver of these neurological abnormalities.
These findings uncover a novel mechanistic axis: DEPTOR → mTOR activity → cholesterol homeostasis → axonal integrity and motor behavior. This is significant for longevity and brain health science because mTOR-pathway dysfunction underlies conditions ranging from age-related cognitive decline to tuberous sclerosis and Alzheimer's disease, and cholesterol metabolism in the brain is increasingly recognized as critical to neuronal function and synaptic plasticity.
Caveats include reliance on a zebrafish model, which limits direct translation to human neurology, and the summary is based on the abstract only, precluding assessment of full methodology, statistical power, or supplementary data.
Key Findings
- Zebrafish lacking DEPTOR develop motor deficits and misaligned, broadened axonal tracts.
- DEPTOR loss triggers progressive, aberrant brain cholesterol accumulation from days 5 to 10.
- Pharmacologically raising cholesterol in normal fish reproduces the axonal and motor defects.
- Clearing excess cholesterol rescues mutant fish, confirming cholesterol as the causal driver.
- Findings link mTOR pathway regulation to neurological health via lipid homeostasis.
Methodology
CRISPR/Cas9 was used to generate deptor knockout zebrafish. Axonal morphology, motor behavior, gene expression, and cholesterol levels were assessed in larvae from 5 to 10 days post-fertilization. Pharmacological gain- and loss-of-function cholesterol experiments were used to confirm causality.
Study Limitations
This study was conducted entirely in zebrafish larvae, and findings may not translate directly to mammalian or human neurobiology. The full paper is not open access; this summary is based on the abstract only, limiting assessment of statistical rigor, sample sizes, and full experimental detail. The clinical relevance of DEPTOR loss-of-function to human neurological disease remains to be established.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: